INVESTABOT
Equity Research
XNYS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-09-28. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-08-20. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-08-13. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-08-03. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-07-27. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
TL;DR: Becton Dickinson filed a report dated July 19, 2026 disclosing a leadership change. The filing text available for analysis does not identify the officer by name, title, or role.
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-06-10. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-06-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
Becton, Dickinson and (BDX) had 1 Form 144 pre-sale notice filed on 2026-05-26. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 4 unique sellers · Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 28, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | -76 | $184 | ~$14K |
| September 2, 2026 | Roque Vitor | EVP & Chief Financial Officer | TAX_WITHHOLD | -190 | — | — |
| August 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | -165 | $188 | ~$31K |
| August 20, 2026 | Feld Michael | EVP, Chief Revenue Officer | TAX_WITHHOLD | -1,049 | — | — |
| August 13, 2026 | Polen Thomas E Jr | Chairman, CEO and President | OPTION_EXERCISE | 43,278 | $167 | ~$7.2M |
| August 13, 2026 | Polen Thomas E Jr | Chairman, CEO and President | DISPOSITION | -39,126 | $185 | ~$7.2M |
| August 13, 2026 | Polen Thomas E Jr | Chairman, CEO and President | SELL | -4,152 | $185 | ~$0.8M |
| August 13, 2026 | Polen Thomas E Jr | Chairman, CEO and President | OPTION_EXERCISE | -43,278 | — | — |
| August 11, 2026 | Goette Roland | EVP and President, EMEA | SELL | -2,438 | $181 | ~$0.4M |
| August 6, 2026 | Huffines Robert Luther | — | GRANT | 189 | $166 | ~$31K |
| August 6, 2026 | Byington Carrie L | — | GRANT | 94 | $166 | ~$16K |
| July 27, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | -75 | $157 | ~$12K |
| July 2, 2026 | Muhsin Bilal | EVP & President Connected Care | TAX_WITHHOLD | -1,935 | — | — |
| July 1, 2026 | Muhsin Bilal | EVP & President Connected Care | GRANT | 14,342 | — | — |
| June 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | -75 | $153 | ~$11K |
| June 24, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | SELL | -1,100 | $146 | ~$0.2M |
| June 10, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | SELL | -1,100 | $151 | ~$0.2M |
| June 1, 2026 | Menziuso Peter | EVP and President, BDI | GRANT | 14,258 | — | — |
| June 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | OPTION_EXERCISE | 20,209 | $126 | ~$2.5M |
| June 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | DISPOSITION | -17,445 | $146 | ~$2.5M |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| September 28, 2026 | Michael Feld | — | 76 | SEC |
| August 26, 2026 | Michael Feld | — | 165 | SEC |
| August 20, 2026 | Richard Byrd | — | 1,330 | SEC |
| August 13, 2026 | Thomas Polen | — | 4,152 | SEC |
| August 11, 2026 | Roland Goette | — | — | SEC |
| August 3, 2026 | Shana Neal | — | 1,500 | SEC |
| July 27, 2026 | Michael Feld | — | 75 | SEC |
| June 26, 2026 | Michael Feld | — | 75 | SEC |
| June 24, 2026 | Michael Garrison | — | 1,100 | SEC |
| June 10, 2026 | Michael Garrison | — | 1,100 | SEC |